Coronavirus Essential | Covaxin phase 3 trials efficacy at 81%, says Bharat Biotech; France looking to secure the Indian vaccine

- --

- -- 1×

Headliner Embed

Embed code See more options

Share

Subscribe

Tune in to the Coronavirus Essential podcast for all the latest updates on the pandemic.

Share

Subscribe

Next

Hot Stocks: City Union, MCX & Amara Raja batteries among top buy ideas

Top episodes

The Market Podcast | Why Airtel rose despite AGR setback and what to do with DMart, Yes Bank and IRCTC

by Moneycontrol Podcast

Interview | Ramesh Damani's thumb rule of 24% returns can make you really rich

by Moneycontrol Podcast

Coronavirus Essential | PM Modi’s lights out, light up message; lockdown may continue until September, says study

by Moneycontrol Podcast

•   Report this episode
•   Download audio
•   QRCode